June 4, 2018

Encorafenib Plus Binimetinib for Metastatic Melanoma

Victor Sandor, MD, discusses the treatment combination at the ASCO 2018 meeting in Chicago.

Victor Sandor, MD, discusses the treatment combination at the ASCO 2018 meeting in Chicago.

Topics:

ASCO 2018 Melanoma Skin Cancer

Next post in ASCO 2018

Differences between the sexes are known in a variety of cancers, but the reasons remain unclear.

Endocrine Therapy Alone Is Not Inferior to Chemoendocrine Therapy in Breast Cancer With Oncotype DX Scores Between 11 and 26